Blueberries Medical Corp BBRRF
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.00–0.02
- Bid/Ask
- $0.01 / $0.01
- Shares Outstanding
- 579.71M
- Market Cap
- $4.50M
- Volume/Avg
- 150,100 / 106,568
Key Statistics
- Price/Earnings (Normalized)
- 20.77
- Price/Sales
- 22.36
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Blueberries Medical Corp is a vertically integrated Consumer Science Company focused on health, wellness, and longevity through science-backed plant bioactives. It specializes in the scalable production and extraction of high-value bioactives derived from a diverse variety of plants native to Latin America. With strategically located operations and a multidisciplinary team of Life Sciences experts, Blueberries plays a vital role in the development of standardized, pharmaceutical-grade ingredients used in functional foods, supplements, and skincare products. It drives the transformation of natural plant compounds into science-based wellness products. The Company supports sustainable sourcing, upholds rigorous production standards, and enables distribution of bioactive solutions.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.blueberriesmed.com
Valuation
|
Metric
|
BBRRF
|
|---|---|
Price/Earnings (Normalized) | 20.77 |
Price/Book Value | 222.73 |
Price/Sales | 22.36 |
Price/Cash Flow | — |
Price/Earnings
BBRRF
Financial Strength
|
Metric
|
BBRRF
|
|---|---|
Quick Ratio | 0.32 |
Current Ratio | 0.44 |
Interest Coverage | — |
Quick Ratio
BBRRF
Profitability
|
Metric
|
BBRRF
|
|---|---|
Return on Assets (Normalized) | −85.31% |
Return on Equity (Normalized) | −172.65% |
Return on Invested Capital (Normalized) | −127.40% |
Return on Assets
BBRRF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|%Y<#mP< | LOCK|pZJ$ | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|jK%rr@R@ | LOCK|^Ns! | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|#TlB?g | LOCK|#q | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|fK<!<j@ | LOCK|>@ | $33B | |||
| Viatris Inc
VTRS
| LOCK|p<nbL&< | LOCK|rc> | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|##S | LOCK|#M | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Vf<G&> | LOCK|$# | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|$@SG!X | LOCK|rRQ | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|!NYR!h& | LOCK|s?x<P | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|tx?B@t& | LOCK|yf | $2B |
United States